Overview
Revenue
$10 to $25 million (USD) per year
Headquarters
San Francisco Bay Area, West Coast, Western US
First Aid Shot Therapy® (FAST) is creating a new market segment defined as “clinical beverages”, designed to address acute or chronic clinical needs of consumers. We offer a range of easy-to-swallow, single-dose products that provide fast-acting relief for your most common everyday symptoms; Hangover, Pain, Sleep, Cold, Allergy, and Heartburn. Every step of FAST’s sourcing, testing, and manufacturing complies with all the requirements of the FDA. A privately held company, FAST was founded in 2010 by Mary Page Platerink, formerly Director of Global Strategic Planning and Global Customer Strategy, and Professor Jay Pasricha, MD, Chief of Gastroenterology and Hepatology at John's Hopkins University. FAST is now available at retailers nationwide and Amazon.com. First Aid Shot Therapy Inc. (F.A.S.T.) develops and commercializes over-the-counter (OTC) medications in liquid shot form. The Company formulates a comprehensive portfolio of OTC pharmaceutical products into proprietary liquid shot (40ml/1.35oz) form. F.A.S.T. markets its products First Aid Shot Therapy is a liquid shot relief for common symptoms.
